| Name | Title | Contact Details |
|---|
NeuWave Medical specializes in developing and commercializing energy-based minimally invasive medical devices. These devices must deliver improved healthcare economics and a better experience for patients in terms of outcomes or quality of life. NeuWave Medical, Inc. is a spin-off company from the University of Wisconsin - Madison. NeuWave arose as the result of an academic collaboration between engineers and physicians who wished to improve their ability to treat cancer and other important clinical problems. As a result, NeuWave is highly focused on solving real clinical problems in a manner that will directly benefit patients by being more effective, minimally invasive, and cost conscious.
Valley Health System is a regional healthcare system that serves residents in northern New Jersey and southern New York. It comprises The Valley Hospital, Valley Home Care and Valley Medical Group. Key services include cardiology, oncology, women’s and children’s services, emergency care, orthopedics and neurosciences. Valley Health System’s Centers of Excellence offer comprehensive coordinated inpatient and outpatient programs and services to help ensure excellent clinical outcomes and quality. The Centers of Excellence include Cardiac/Heart Failure, Diabetes, Oncology, Pulmonary, Geriatrics, Total Joint and Neurovascular. Valley maintains affiliations and collaborations with Mount Sinai Health System and with Cleveland Clinic’s Sydell and Arnold Miller Family Heart & Vascular Institute.
Health People is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
GGB Industries Inc is a Naples, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.